The MemClin project: a prospective multi memory clinics study targeting early stages of cognitive impairment.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
06 03 2020
Historique:
received: 21 12 2018
accepted: 17 02 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 15 12 2020
Statut: epublish

Résumé

There remains a lack of large-scale clinical studies of cognitive impairment that aim to increase diagnostic and prognostic accuracy as well as validate previous research findings. The MemClin project will amass large quantities of cross-disciplinary data allowing for the construction of robust models to improve diagnostic accuracy, expand our knowledge on differential diagnostics, strengthen longitudinal prognosis, and harmonise examination protocols across centres. The current article describes the Memory Clinic (MemClin) project's study-design, materials and methods, and patient characteristics. In addition, we present preliminary descriptive data from the ongoing data collection. Nine out of ten memory clinics in the greater Stockholm area, which largely use the same examination methods, are included. The data collection of patients with different stages of cognitive impairment and dementia is coordinated centrally allowing for efficient and secure large-scale database construction. The MemClin project rest directly on the memory clinics examinations with cognitive measures, health parameters, and biomarkers. Currently, the MemClin project has informed consent from 1543 patients. Herein, we present preliminary data from 835 patients with confirmed cognitive diagnosis and neuropsychological test data available. Of those, 239 had dementia, 487 mild cognitive impairment (MCI), and 104 subjective cognitive impairment (SCI). In addition, we present descriptive data on visual ratings of brain atrophy and cerebrospinal fluid markers. Based on our current progress and preliminary data, the MemClin project has a high potential to provide a large-scale database of 1200-1500 new patients annually. This coordinated data collection will allow for the construction of improved diagnostic and prognostic models for neurodegenerative disorders and other cognitive conditions in their naturalistic setting.

Sections du résumé

BACKGROUND
There remains a lack of large-scale clinical studies of cognitive impairment that aim to increase diagnostic and prognostic accuracy as well as validate previous research findings. The MemClin project will amass large quantities of cross-disciplinary data allowing for the construction of robust models to improve diagnostic accuracy, expand our knowledge on differential diagnostics, strengthen longitudinal prognosis, and harmonise examination protocols across centres. The current article describes the Memory Clinic (MemClin) project's study-design, materials and methods, and patient characteristics. In addition, we present preliminary descriptive data from the ongoing data collection.
METHODS
Nine out of ten memory clinics in the greater Stockholm area, which largely use the same examination methods, are included. The data collection of patients with different stages of cognitive impairment and dementia is coordinated centrally allowing for efficient and secure large-scale database construction. The MemClin project rest directly on the memory clinics examinations with cognitive measures, health parameters, and biomarkers.
RESULTS
Currently, the MemClin project has informed consent from 1543 patients. Herein, we present preliminary data from 835 patients with confirmed cognitive diagnosis and neuropsychological test data available. Of those, 239 had dementia, 487 mild cognitive impairment (MCI), and 104 subjective cognitive impairment (SCI). In addition, we present descriptive data on visual ratings of brain atrophy and cerebrospinal fluid markers.
CONCLUSIONS
Based on our current progress and preliminary data, the MemClin project has a high potential to provide a large-scale database of 1200-1500 new patients annually. This coordinated data collection will allow for the construction of improved diagnostic and prognostic models for neurodegenerative disorders and other cognitive conditions in their naturalistic setting.

Identifiants

pubmed: 32138686
doi: 10.1186/s12877-020-1478-3
pii: 10.1186/s12877-020-1478-3
pmc: PMC7059672
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

93

Subventions

Organisme : Vetenskapsrådet
ID : 2016-01840
Pays : International
Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : 2015-00174
Pays : International

Références

J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967-72
pubmed: 1431963
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Alzheimers Dement. 2014 Nov;10(6):844-52
pubmed: 24798886
Eur Neurol. 1997;37(2):95-9
pubmed: 9058064
Neuroimaging Clin N Am. 2005 Nov;15(4):869-77, xi-xii
pubmed: 16443497
Soc Psychiatry Psychiatr Epidemiol. 2019 Jan;54(1):1-10
pubmed: 30467589
Int J Geriatr Psychiatry. 2011 Jan;26(1):75-82
pubmed: 21157852
Front Neuroinform. 2014 Jan 06;7:49
pubmed: 24432000
PLoS One. 2015 Feb 19;10(2):e0116538
pubmed: 25695768
Alzheimers Res Ther. 2018 Jul 6;10(1):64
pubmed: 29980228
Neurology. 2016 Aug 2;87(5):539-47
pubmed: 27371494
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Neurology. 2017 Jun 6;88(23):2225-2232
pubmed: 28490651
Psychol Aging. 1996 Dec;11(4):621-37
pubmed: 9000294
J Alzheimers Dis. 2018;66(2):483-495
pubmed: 30320572
Alzheimers Dement. 2019 Mar;15(3):465-476
pubmed: 30555032
J Neurol Neurosurg Psychiatry. 2010 May;81(5):541-6
pubmed: 19965857
Sci Rep. 2018 May 30;8(1):8431
pubmed: 29849029
Stroke. 2001 Jun;32(6):1318-22
pubmed: 11387493
Ther Adv Neurol Disord. 2012 Nov;5(6):335-48
pubmed: 23139704
Int Psychogeriatr. 1997;9 Suppl 1:65-9
pubmed: 9447429
Acta Psychiatr Scand. 2009 Apr;119(4):252-65
pubmed: 19236314
Alzheimers Dement. 2017 Mar;13(3):296-311
pubmed: 27825022
Alzheimers Dement. 2018 Jun;14(6):837-842
pubmed: 29604264
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
Eur J Epidemiol. 2018 Jul;33(7):613-616
pubmed: 29931437
Alzheimers Res Ther. 2018 Feb 07;10(1):15
pubmed: 29415768
Neurobiol Aging. 2018 Nov;71:179-188
pubmed: 30149289

Auteurs

Urban Ekman (U)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden. urban.ekman@ki.se.
Theme Aging, Karolinska University Hospital, Huddinge, Sweden. urban.ekman@ki.se.

Daniel Ferreira (D)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.

J-Sebastian Muehlboeck (JS)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.

John Wallert (J)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Anna Rennie (A)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.

Maria Eriksdotter (M)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.
Theme Aging, Karolinska University Hospital, Huddinge, Sweden.

Lars-Olof Wahlund (LO)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.

Eric Westman (E)

Department of Neurobiology, Care Sciences, and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience: King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH